ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global AI Pharma Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-7D11664
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global AI Pharma Market Research Report 2022
BUY CHAPTERS

Global AI Pharma Market Research Report 2024

Code: QYRE-Auto-7D11664
Report
April 2024
Pages:102
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
InSilico Medicine
Exscientia Ltd
BenevolentAI
Atomwise
Roivant Sciences
Schrödinger
XtalPi
Landos Biopharma
Deep Genomics
Recursion
Lantern Pharma
Relay Therapeutics
Accutar Biotech
Oncocross
AI Therapeutics
BioMap
METiS Pharmaceuticals
NeoX Biotech
StoneWise
Deep Intelligent Pharma
Gigaceuticals
Chemical.AI
Artivila
Galixir
Xbiome

AI Pharma Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

AI Pharma Market

AI Pharma Market

The global AI Pharma market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for AI Pharma, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI Pharma.

Report Scope

The AI Pharma market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global AI Pharma market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI Pharma companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of AI Pharma Market Report

Report Metric Details
Report Name AI Pharma Market
CAGR 5%
Segment by Type
  • Self-developed Oipeline
  • Contract Research Organization (CRO)
  • Other
Segment by Application
  • Preclinical Stage (Optimization of Lead Compounds, etc.)
  • Clinical Trial Phase (Predicting Treatment Outcome, etc.)
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Recursion, Insilico Medicine, Exscientia, BenevolentAI, Atomwise, Roivant Sciences, Schrödinger, Lantern Pharma, XtalPi, Landos Biopharma, Relay Therapeutics, Accutar Biotech, Deep Genomics, Oncocross, AI Therapeutics, BioMap, METiS Pharmaceuticals, NeoX Biotech, StoneWise, Deep Intelligent Pharma, Gigaceuticals, Chemical.AI, Artivila, Galixir, Xbiome
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of AI Pharma companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the AI Pharma Market report?

Ans: The main players in the AI Pharma Market are Recursion, Insilico Medicine, Exscientia, BenevolentAI, Atomwise, Roivant Sciences, Schrödinger, Lantern Pharma, XtalPi, Landos Biopharma, Relay Therapeutics, Accutar Biotech, Deep Genomics, Oncocross, AI Therapeutics, BioMap, METiS Pharmaceuticals, NeoX Biotech, StoneWise, Deep Intelligent Pharma, Gigaceuticals, Chemical.AI, Artivila, Galixir, Xbiome

What are the Application segmentation covered in the AI Pharma Market report?

Ans: The Applications covered in the AI Pharma Market report are Preclinical Stage (Optimization of Lead Compounds, etc.), Clinical Trial Phase (Predicting Treatment Outcome, etc.)

What are the Type segmentation covered in the AI Pharma Market report?

Ans: The Types covered in the AI Pharma Market report are Self-developed Oipeline, Contract Research Organization (CRO), Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI Pharma Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Self-developed Oipeline
1.2.3 Contract Research Organization (CRO)
1.2.4 Other
1.3 Market by Application
1.3.1 Global AI Pharma Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Preclinical Stage (Optimization of Lead Compounds, etc.)
1.3.3 Clinical Trial Phase (Predicting Treatment Outcome, etc.)
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI Pharma Market Perspective (2019-2030)
2.2 AI Pharma Growth Trends by Region
2.2.1 Global AI Pharma Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 AI Pharma Historic Market Size by Region (2019-2024)
2.2.3 AI Pharma Forecasted Market Size by Region (2025-2030)
2.3 AI Pharma Market Dynamics
2.3.1 AI Pharma Industry Trends
2.3.2 AI Pharma Market Drivers
2.3.3 AI Pharma Market Challenges
2.3.4 AI Pharma Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI Pharma Players by Revenue
3.1.1 Global Top AI Pharma Players by Revenue (2019-2024)
3.1.2 Global AI Pharma Revenue Market Share by Players (2019-2024)
3.2 Global AI Pharma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by AI Pharma Revenue
3.4 Global AI Pharma Market Concentration Ratio
3.4.1 Global AI Pharma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI Pharma Revenue in 2023
3.5 AI Pharma Key Players Head office and Area Served
3.6 Key Players AI Pharma Product Solution and Service
3.7 Date of Enter into AI Pharma Market
3.8 Mergers & Acquisitions, Expansion Plans
4 AI Pharma Breakdown Data by Type
4.1 Global AI Pharma Historic Market Size by Type (2019-2024)
4.2 Global AI Pharma Forecasted Market Size by Type (2025-2030)
5 AI Pharma Breakdown Data by Application
5.1 Global AI Pharma Historic Market Size by Application (2019-2024)
5.2 Global AI Pharma Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America AI Pharma Market Size (2019-2030)
6.2 North America AI Pharma Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America AI Pharma Market Size by Country (2019-2024)
6.4 North America AI Pharma Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI Pharma Market Size (2019-2030)
7.2 Europe AI Pharma Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe AI Pharma Market Size by Country (2019-2024)
7.4 Europe AI Pharma Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI Pharma Market Size (2019-2030)
8.2 Asia-Pacific AI Pharma Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific AI Pharma Market Size by Region (2019-2024)
8.4 Asia-Pacific AI Pharma Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI Pharma Market Size (2019-2030)
9.2 Latin America AI Pharma Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America AI Pharma Market Size by Country (2019-2024)
9.4 Latin America AI Pharma Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI Pharma Market Size (2019-2030)
10.2 Middle East & Africa AI Pharma Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa AI Pharma Market Size by Country (2019-2024)
10.4 Middle East & Africa AI Pharma Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Recursion
11.1.1 Recursion Company Detail
11.1.2 Recursion Business Overview
11.1.3 Recursion AI Pharma Introduction
11.1.4 Recursion Revenue in AI Pharma Business (2019-2024)
11.1.5 Recursion Recent Development
11.2 Insilico Medicine
11.2.1 Insilico Medicine Company Detail
11.2.2 Insilico Medicine Business Overview
11.2.3 Insilico Medicine AI Pharma Introduction
11.2.4 Insilico Medicine Revenue in AI Pharma Business (2019-2024)
11.2.5 Insilico Medicine Recent Development
11.3 Exscientia
11.3.1 Exscientia Company Detail
11.3.2 Exscientia Business Overview
11.3.3 Exscientia AI Pharma Introduction
11.3.4 Exscientia Revenue in AI Pharma Business (2019-2024)
11.3.5 Exscientia Recent Development
11.4 BenevolentAI
11.4.1 BenevolentAI Company Detail
11.4.2 BenevolentAI Business Overview
11.4.3 BenevolentAI AI Pharma Introduction
11.4.4 BenevolentAI Revenue in AI Pharma Business (2019-2024)
11.4.5 BenevolentAI Recent Development
11.5 Atomwise
11.5.1 Atomwise Company Detail
11.5.2 Atomwise Business Overview
11.5.3 Atomwise AI Pharma Introduction
11.5.4 Atomwise Revenue in AI Pharma Business (2019-2024)
11.5.5 Atomwise Recent Development
11.6 Roivant Sciences
11.6.1 Roivant Sciences Company Detail
11.6.2 Roivant Sciences Business Overview
11.6.3 Roivant Sciences AI Pharma Introduction
11.6.4 Roivant Sciences Revenue in AI Pharma Business (2019-2024)
11.6.5 Roivant Sciences Recent Development
11.7 Schrödinger
11.7.1 Schrödinger Company Detail
11.7.2 Schrödinger Business Overview
11.7.3 Schrödinger AI Pharma Introduction
11.7.4 Schrödinger Revenue in AI Pharma Business (2019-2024)
11.7.5 Schrödinger Recent Development
11.8 Lantern Pharma
11.8.1 Lantern Pharma Company Detail
11.8.2 Lantern Pharma Business Overview
11.8.3 Lantern Pharma AI Pharma Introduction
11.8.4 Lantern Pharma Revenue in AI Pharma Business (2019-2024)
11.8.5 Lantern Pharma Recent Development
11.9 XtalPi
11.9.1 XtalPi Company Detail
11.9.2 XtalPi Business Overview
11.9.3 XtalPi AI Pharma Introduction
11.9.4 XtalPi Revenue in AI Pharma Business (2019-2024)
11.9.5 XtalPi Recent Development
11.10 Landos Biopharma
11.10.1 Landos Biopharma Company Detail
11.10.2 Landos Biopharma Business Overview
11.10.3 Landos Biopharma AI Pharma Introduction
11.10.4 Landos Biopharma Revenue in AI Pharma Business (2019-2024)
11.10.5 Landos Biopharma Recent Development
11.11 Relay Therapeutics
11.11.1 Relay Therapeutics Company Detail
11.11.2 Relay Therapeutics Business Overview
11.11.3 Relay Therapeutics AI Pharma Introduction
11.11.4 Relay Therapeutics Revenue in AI Pharma Business (2019-2024)
11.11.5 Relay Therapeutics Recent Development
11.12 Accutar Biotech
11.12.1 Accutar Biotech Company Detail
11.12.2 Accutar Biotech Business Overview
11.12.3 Accutar Biotech AI Pharma Introduction
11.12.4 Accutar Biotech Revenue in AI Pharma Business (2019-2024)
11.12.5 Accutar Biotech Recent Development
11.13 Deep Genomics
11.13.1 Deep Genomics Company Detail
11.13.2 Deep Genomics Business Overview
11.13.3 Deep Genomics AI Pharma Introduction
11.13.4 Deep Genomics Revenue in AI Pharma Business (2019-2024)
11.13.5 Deep Genomics Recent Development
11.14 Oncocross
11.14.1 Oncocross Company Detail
11.14.2 Oncocross Business Overview
11.14.3 Oncocross AI Pharma Introduction
11.14.4 Oncocross Revenue in AI Pharma Business (2019-2024)
11.14.5 Oncocross Recent Development
11.15 AI Therapeutics
11.15.1 AI Therapeutics Company Detail
11.15.2 AI Therapeutics Business Overview
11.15.3 AI Therapeutics AI Pharma Introduction
11.15.4 AI Therapeutics Revenue in AI Pharma Business (2019-2024)
11.15.5 AI Therapeutics Recent Development
11.16 BioMap
11.16.1 BioMap Company Detail
11.16.2 BioMap Business Overview
11.16.3 BioMap AI Pharma Introduction
11.16.4 BioMap Revenue in AI Pharma Business (2019-2024)
11.16.5 BioMap Recent Development
11.17 METiS Pharmaceuticals
11.17.1 METiS Pharmaceuticals Company Detail
11.17.2 METiS Pharmaceuticals Business Overview
11.17.3 METiS Pharmaceuticals AI Pharma Introduction
11.17.4 METiS Pharmaceuticals Revenue in AI Pharma Business (2019-2024)
11.17.5 METiS Pharmaceuticals Recent Development
11.18 NeoX Biotech
11.18.1 NeoX Biotech Company Detail
11.18.2 NeoX Biotech Business Overview
11.18.3 NeoX Biotech AI Pharma Introduction
11.18.4 NeoX Biotech Revenue in AI Pharma Business (2019-2024)
11.18.5 NeoX Biotech Recent Development
11.19 StoneWise
11.19.1 StoneWise Company Detail
11.19.2 StoneWise Business Overview
11.19.3 StoneWise AI Pharma Introduction
11.19.4 StoneWise Revenue in AI Pharma Business (2019-2024)
11.19.5 StoneWise Recent Development
11.20 Deep Intelligent Pharma
11.20.1 Deep Intelligent Pharma Company Detail
11.20.2 Deep Intelligent Pharma Business Overview
11.20.3 Deep Intelligent Pharma AI Pharma Introduction
11.20.4 Deep Intelligent Pharma Revenue in AI Pharma Business (2019-2024)
11.20.5 Deep Intelligent Pharma Recent Development
11.21 Gigaceuticals
11.21.1 Gigaceuticals Company Detail
11.21.2 Gigaceuticals Business Overview
11.21.3 Gigaceuticals AI Pharma Introduction
11.21.4 Gigaceuticals Revenue in AI Pharma Business (2019-2024)
11.21.5 Gigaceuticals Recent Development
11.22 Chemical.AI
11.22.1 Chemical.AI Company Detail
11.22.2 Chemical.AI Business Overview
11.22.3 Chemical.AI AI Pharma Introduction
11.22.4 Chemical.AI Revenue in AI Pharma Business (2019-2024)
11.22.5 Chemical.AI Recent Development
11.23 Artivila
11.23.1 Artivila Company Detail
11.23.2 Artivila Business Overview
11.23.3 Artivila AI Pharma Introduction
11.23.4 Artivila Revenue in AI Pharma Business (2019-2024)
11.23.5 Artivila Recent Development
11.24 Galixir
11.24.1 Galixir Company Detail
11.24.2 Galixir Business Overview
11.24.3 Galixir AI Pharma Introduction
11.24.4 Galixir Revenue in AI Pharma Business (2019-2024)
11.24.5 Galixir Recent Development
11.25 Xbiome
11.25.1 Xbiome Company Detail
11.25.2 Xbiome Business Overview
11.25.3 Xbiome AI Pharma Introduction
11.25.4 Xbiome Revenue in AI Pharma Business (2019-2024)
11.25.5 Xbiome Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
InSilico Medicine
Exscientia Ltd
BenevolentAI
Atomwise
Roivant Sciences
Schrödinger
XtalPi
Landos Biopharma
Deep Genomics
Recursion
Lantern Pharma
Relay Therapeutics
Accutar Biotech
Oncocross
AI Therapeutics
BioMap
METiS Pharmaceuticals
NeoX Biotech
StoneWise
Deep Intelligent Pharma
Gigaceuticals
Chemical.AI
Artivila
Galixir
Xbiome
List of Tables
    Table 1. Global AI Pharma Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Self-developed Oipeline
    Table 3. Key Players of Contract Research Organization (CRO)
    Table 4. Key Players of Other
    Table 5. Global AI Pharma Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global AI Pharma Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global AI Pharma Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global AI Pharma Market Share by Region (2019-2024)
    Table 9. Global AI Pharma Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global AI Pharma Market Share by Region (2025-2030)
    Table 11. AI Pharma Market Trends
    Table 12. AI Pharma Market Drivers
    Table 13. AI Pharma Market Challenges
    Table 14. AI Pharma Market Restraints
    Table 15. Global AI Pharma Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global AI Pharma Market Share by Players (2019-2024)
    Table 17. Global Top AI Pharma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Pharma as of 2023)
    Table 18. Ranking of Global Top AI Pharma Companies by Revenue (US$ Million) in 2023
    Table 19. Global 5 Largest Players Market Share by AI Pharma Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players AI Pharma Product Solution and Service
    Table 22. Date of Enter into AI Pharma Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global AI Pharma Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global AI Pharma Revenue Market Share by Type (2019-2024)
    Table 26. Global AI Pharma Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global AI Pharma Revenue Market Share by Type (2025-2030)
    Table 28. Global AI Pharma Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global AI Pharma Revenue Market Share by Application (2019-2024)
    Table 30. Global AI Pharma Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global AI Pharma Revenue Market Share by Application (2025-2030)
    Table 32. North America AI Pharma Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 33. North America AI Pharma Market Size by Country (2019-2024) & (US$ Million)
    Table 34. North America AI Pharma Market Size by Country (2025-2030) & (US$ Million)
    Table 35. Europe AI Pharma Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. Europe AI Pharma Market Size by Country (2019-2024) & (US$ Million)
    Table 37. Europe AI Pharma Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Asia-Pacific AI Pharma Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 39. Asia-Pacific AI Pharma Market Size by Region (2019-2024) & (US$ Million)
    Table 40. Asia-Pacific AI Pharma Market Size by Region (2025-2030) & (US$ Million)
    Table 41. Latin America AI Pharma Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 42. Latin America AI Pharma Market Size by Country (2019-2024) & (US$ Million)
    Table 43. Latin America AI Pharma Market Size by Country (2025-2030) & (US$ Million)
    Table 44. Middle East & Africa AI Pharma Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Middle East & Africa AI Pharma Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Middle East & Africa AI Pharma Market Size by Country (2025-2030) & (US$ Million)
    Table 47. Recursion Company Detail
    Table 48. Recursion Business Overview
    Table 49. Recursion AI Pharma Product
    Table 50. Recursion Revenue in AI Pharma Business (2019-2024) & (US$ Million)
    Table 51. Recursion Recent Development
    Table 52. Insilico Medicine Company Detail
    Table 53. Insilico Medicine Business Overview
    Table 54. Insilico Medicine AI Pharma Product
    Table 55. Insilico Medicine Revenue in AI Pharma Business (2019-2024) & (US$ Million)
    Table 56. Insilico Medicine Recent Development
    Table 57. Exscientia Company Detail
    Table 58. Exscientia Business Overview
    Table 59. Exscientia AI Pharma Product
    Table 60. Exscientia Revenue in AI Pharma Business (2019-2024) & (US$ Million)
    Table 61. Exscientia Recent Development
    Table 62. BenevolentAI Company Detail
    Table 63. BenevolentAI Business Overview
    Table 64. BenevolentAI AI Pharma Product
    Table 65. BenevolentAI Revenue in AI Pharma Business (2019-2024) & (US$ Million)
    Table 66. BenevolentAI Recent Development
    Table 67. Atomwise Company Detail
    Table 68. Atomwise Business Overview
    Table 69. Atomwise AI Pharma Product
    Table 70. Atomwise Revenue in AI Pharma Business (2019-2024) & (US$ Million)
    Table 71. Atomwise Recent Development
    Table 72. Roivant Sciences Company Detail
    Table 73. Roivant Sciences Business Overview
    Table 74. Roivant Sciences AI Pharma Product
    Table 75. Roivant Sciences Revenue in AI Pharma Business (2019-2024) & (US$ Million)
    Table 76. Roivant Sciences Recent Development
    Table 77. Schrödinger Company Detail
    Table 78. Schrödinger Business Overview
    Table 79. Schrödinger AI Pharma Product
    Table 80. Schrödinger Revenue in AI Pharma Business (2019-2024) & (US$ Million)
    Table 81. Schrödinger Recent Development
    Table 82. Lantern Pharma Company Detail
    Table 83. Lantern Pharma Business Overview
    Table 84. Lantern Pharma AI Pharma Product
    Table 85. Lantern Pharma Revenue in AI Pharma Business (2019-2024) & (US$ Million)
    Table 86. Lantern Pharma Recent Development
    Table 87. XtalPi Company Detail
    Table 88. XtalPi Business Overview
    Table 89. XtalPi AI Pharma Product
    Table 90. XtalPi Revenue in AI Pharma Business (2019-2024) & (US$ Million)
    Table 91. XtalPi Recent Development
    Table 92. Landos Biopharma Company Detail
    Table 93. Landos Biopharma Business Overview
    Table 94. Landos Biopharma AI Pharma Product
    Table 95. Landos Biopharma Revenue in AI Pharma Business (2019-2024) & (US$ Million)
    Table 96. Landos Biopharma Recent Development
    Table 97. Relay Therapeutics Company Detail
    Table 98. Relay Therapeutics Business Overview
    Table 99. Relay Therapeutics AI Pharma Product
    Table 100. Relay Therapeutics Revenue in AI Pharma Business (2019-2024) & (US$ Million)
    Table 101. Relay Therapeutics Recent Development
    Table 102. Accutar Biotech Company Detail
    Table 103. Accutar Biotech Business Overview
    Table 104. Accutar Biotech AI Pharma Product
    Table 105. Accutar Biotech Revenue in AI Pharma Business (2019-2024) & (US$ Million)
    Table 106. Accutar Biotech Recent Development
    Table 107. Deep Genomics Company Detail
    Table 108. Deep Genomics Business Overview
    Table 109. Deep Genomics AI Pharma Product
    Table 110. Deep Genomics Revenue in AI Pharma Business (2019-2024) & (US$ Million)
    Table 111. Deep Genomics Recent Development
    Table 112. Oncocross Company Detail
    Table 113. Oncocross Business Overview
    Table 114. Oncocross AI Pharma Product
    Table 115. Oncocross Revenue in AI Pharma Business (2019-2024) & (US$ Million)
    Table 116. Oncocross Recent Development
    Table 117. AI Therapeutics Company Detail
    Table 118. AI Therapeutics Business Overview
    Table 119. AI Therapeutics AI Pharma Product
    Table 120. AI Therapeutics Revenue in AI Pharma Business (2019-2024) & (US$ Million)
    Table 121. AI Therapeutics Recent Development
    Table 122. BioMap Company Detail
    Table 123. BioMap Business Overview
    Table 124. BioMap AI Pharma Product
    Table 125. BioMap Revenue in AI Pharma Business (2019-2024) & (US$ Million)
    Table 126. BioMap Recent Development
    Table 127. METiS Pharmaceuticals Company Detail
    Table 128. METiS Pharmaceuticals Business Overview
    Table 129. METiS Pharmaceuticals AI Pharma Product
    Table 130. METiS Pharmaceuticals Revenue in AI Pharma Business (2019-2024) & (US$ Million)
    Table 131. METiS Pharmaceuticals Recent Development
    Table 132. NeoX Biotech Company Detail
    Table 133. NeoX Biotech Business Overview
    Table 134. NeoX Biotech AI Pharma Product
    Table 135. NeoX Biotech Revenue in AI Pharma Business (2019-2024) & (US$ Million)
    Table 136. NeoX Biotech Recent Development
    Table 137. StoneWise Company Detail
    Table 138. StoneWise Business Overview
    Table 139. StoneWise AI Pharma Product
    Table 140. StoneWise Revenue in AI Pharma Business (2019-2024) & (US$ Million)
    Table 141. StoneWise Recent Development
    Table 142. Deep Intelligent Pharma Company Detail
    Table 143. Deep Intelligent Pharma Business Overview
    Table 144. Deep Intelligent Pharma AI Pharma Product
    Table 145. Deep Intelligent Pharma Revenue in AI Pharma Business (2019-2024) & (US$ Million)
    Table 146. Deep Intelligent Pharma Recent Development
    Table 147. Gigaceuticals Company Detail
    Table 148. Gigaceuticals Business Overview
    Table 149. Gigaceuticals AI Pharma Product
    Table 150. Gigaceuticals Revenue in AI Pharma Business (2019-2024) & (US$ Million)
    Table 151. Gigaceuticals Recent Development
    Table 152. Chemical.AI Company Detail
    Table 153. Chemical.AI Business Overview
    Table 154. Chemical.AI AI Pharma Product
    Table 155. Chemical.AI Revenue in AI Pharma Business (2019-2024) & (US$ Million)
    Table 156. Chemical.AI Recent Development
    Table 157. Artivila Company Detail
    Table 158. Artivila Business Overview
    Table 159. Artivila AI Pharma Product
    Table 160. Artivila Revenue in AI Pharma Business (2019-2024) & (US$ Million)
    Table 161. Artivila Recent Development
    Table 162. Galixir Company Detail
    Table 163. Galixir Business Overview
    Table 164. Galixir AI Pharma Product
    Table 165. Galixir Revenue in AI Pharma Business (2019-2024) & (US$ Million)
    Table 166. Galixir Recent Development
    Table 167. Xbiome Company Detail
    Table 168. Xbiome Business Overview
    Table 169. Xbiome AI Pharma Product
    Table 170. Xbiome Revenue in AI Pharma Business (2019-2024) & (US$ Million)
    Table 171. Xbiome Recent Development
    Table 172. Research Programs/Design for This Report
    Table 173. Key Data Information from Secondary Sources
    Table 174. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global AI Pharma Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global AI Pharma Market Share by Type: 2023 VS 2030
    Figure 3. Self-developed Oipeline Features
    Figure 4. Contract Research Organization (CRO) Features
    Figure 5. Other Features
    Figure 6. Global AI Pharma Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global AI Pharma Market Share by Application: 2023 VS 2030
    Figure 8. Preclinical Stage (Optimization of Lead Compounds, etc.) Case Studies
    Figure 9. Clinical Trial Phase (Predicting Treatment Outcome, etc.) Case Studies
    Figure 10. AI Pharma Report Years Considered
    Figure 11. Global AI Pharma Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global AI Pharma Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global AI Pharma Market Share by Region: 2023 VS 2030
    Figure 14. Global AI Pharma Market Share by Players in 2023
    Figure 15. Global Top AI Pharma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Pharma as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by AI Pharma Revenue in 2023
    Figure 17. North America AI Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America AI Pharma Market Share by Country (2019-2030)
    Figure 19. United States AI Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. Canada AI Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Europe AI Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe AI Pharma Market Share by Country (2019-2030)
    Figure 23. Germany AI Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. France AI Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. U.K. AI Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Italy AI Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Russia AI Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Nordic Countries AI Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Asia-Pacific AI Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Asia-Pacific AI Pharma Market Share by Region (2019-2030)
    Figure 31. China AI Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Japan AI Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. South Korea AI Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Southeast Asia AI Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. India AI Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Australia AI Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Latin America AI Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Latin America AI Pharma Market Share by Country (2019-2030)
    Figure 39. Mexico AI Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Brazil AI Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Middle East & Africa AI Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Middle East & Africa AI Pharma Market Share by Country (2019-2030)
    Figure 43. Turkey AI Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Saudi Arabia AI Pharma Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Recursion Revenue Growth Rate in AI Pharma Business (2019-2024)
    Figure 46. Insilico Medicine Revenue Growth Rate in AI Pharma Business (2019-2024)
    Figure 47. Exscientia Revenue Growth Rate in AI Pharma Business (2019-2024)
    Figure 48. BenevolentAI Revenue Growth Rate in AI Pharma Business (2019-2024)
    Figure 49. Atomwise Revenue Growth Rate in AI Pharma Business (2019-2024)
    Figure 50. Roivant Sciences Revenue Growth Rate in AI Pharma Business (2019-2024)
    Figure 51. Schrödinger Revenue Growth Rate in AI Pharma Business (2019-2024)
    Figure 52. Lantern Pharma Revenue Growth Rate in AI Pharma Business (2019-2024)
    Figure 53. XtalPi Revenue Growth Rate in AI Pharma Business (2019-2024)
    Figure 54. Landos Biopharma Revenue Growth Rate in AI Pharma Business (2019-2024)
    Figure 55. Relay Therapeutics Revenue Growth Rate in AI Pharma Business (2019-2024)
    Figure 56. Accutar Biotech Revenue Growth Rate in AI Pharma Business (2019-2024)
    Figure 57. Deep Genomics Revenue Growth Rate in AI Pharma Business (2019-2024)
    Figure 58. Oncocross Revenue Growth Rate in AI Pharma Business (2019-2024)
    Figure 59. AI Therapeutics Revenue Growth Rate in AI Pharma Business (2019-2024)
    Figure 60. BioMap Revenue Growth Rate in AI Pharma Business (2019-2024)
    Figure 61. METiS Pharmaceuticals Revenue Growth Rate in AI Pharma Business (2019-2024)
    Figure 62. NeoX Biotech Revenue Growth Rate in AI Pharma Business (2019-2024)
    Figure 63. StoneWise Revenue Growth Rate in AI Pharma Business (2019-2024)
    Figure 64. Deep Intelligent Pharma Revenue Growth Rate in AI Pharma Business (2019-2024)
    Figure 65. Gigaceuticals Revenue Growth Rate in AI Pharma Business (2019-2024)
    Figure 66. Chemical.AI Revenue Growth Rate in AI Pharma Business (2019-2024)
    Figure 67. Artivila Revenue Growth Rate in AI Pharma Business (2019-2024)
    Figure 68. Galixir Revenue Growth Rate in AI Pharma Business (2019-2024)
    Figure 69. Xbiome Revenue Growth Rate in AI Pharma Business (2019-2024)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Pharmaceutical Rubber Stoppers and Seals Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-0V8134
Sat May 11 00:00:00 UTC 2024

Add to Cart

Global Marine Biopharmaceutical Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-2C6281
Sat May 11 00:00:00 UTC 2024

Add to Cart

Global Medicine Bottle Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-39C4098
Sat May 11 00:00:00 UTC 2024

Add to Cart

Global UV Sterilizer For Medical Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-10O7850
Sat May 11 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions